Stay updated on T-DXd in HER2 Expressing Tumors Clinical Trial
Sign up to get notified when there's something new on the T-DXd in HER2 Expressing Tumors Clinical Trial page.

Latest updates to the T-DXd in HER2 Expressing Tumors Clinical Trial page
- CheckyesterdayChange DetectedThe page now displays Revision: v3.6.4, updating the site version tag from v3.6.3 to v3.6.4, which reflects a backend/template update rather than changes to trial details.SummaryDifference0.0%

- Check8 days agoNo Change Detected
- Check16 days agoChange DetectedRecent updates were added to the study record with July 2026 timestamps, and older April 2026 timestamps were removed. This alters the visible update timeline and indicates renewed record-keeping activity for the study.SummaryDifference0.1%

- Check23 days agoChange DetectedThe revision tag at the bottom of the page updated from v3.6.2 to v3.6.3, indicating a new page release or update rather than a change to study details. This is a metadata-level update and does not alter the study content.SummaryDifference0.0%

- Check30 days agoChange DetectedThe page's revision tag was updated to v3.6.2, replacing v3.6.0, indicating a backend/template update without changes to the study details.SummaryDifference0.0%

- Check37 days agoChange DetectedA new publication citation related to DESTINY-PanTumor02 was added to Publications, including the authors, journal, DOI, and Epub date; the Online ahead of print note for that citation was removed.SummaryDifference0.0%

- Check44 days agoChange DetectedEnrollment status updated to indicate recruitment is closed, and new user guidance sections were added (How to Read a Study Record, Common Questions, How to Join a Study). The page also shows a revision to v3.6.0 and a removal of the Intervention/Treatment label, reflecting content restructuring.SummaryDifference0.2%

Stay in the know with updates to T-DXd in HER2 Expressing Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the T-DXd in HER2 Expressing Tumors Clinical Trial page.